# SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
> **ANDA087999** · Abbreviated New Drug Application (Generic) · Sponsor: PUREPAC PHARM · Approved 1985-11-06
## Drug
- **FDA Application Number:** ANDA087999
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PUREPAC PHARM
- **First approval:** 1985-11-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087999)
---
*MORVS · CC0 1.0*